======= WDR7 =======
== Gene Information ==
* **Official Symbol**: WDR7
* **Official Name**: WD repeat domain 7
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23335|23335]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y4E6|Q9Y4E6]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=WDR7&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20WDR7|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/613473|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: N/A
|WD40|
|hematopoietic progenitor cell differentiation|
|synaptic vesicle|
|hemopoiesis|
|hematopoietic or lymphoid organ development|
|immune system development|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|-2.47|
|[[:results:exp79|Q15 2.7μM R02 exp79]]|-2.43|
|[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-2.4|
|[[:results:exp111|R-DABN 8μM R03 exp111]]|-2.18|
|[[:results:exp329|Hydroxyurea 100μM R07 exp329]]|-2.12|
|[[:results:exp7|Bortezomib 0.05μM R00 exp7]]|-2.05|
|[[:results:exp445|∆-9-Tetrahydrocannabinol 30μM R08 exp445]]|-1.99|
|[[:results:exp336|Asunaprenir 3μM R07 exp336]]|-1.95|
|[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|-1.9|
|[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-1.89|
|[[:results:exp456|Benzoate 20000μM R08 exp456]]|-1.86|
|[[:results:exp32|Rifampicin 10μM R00 exp32]]|-1.8|
|[[:results:exp227|Cryptotanshinone 12μM R05 exp227]]|-1.79|
|[[:results:exp182|IU1-47 25μM R04 exp182]]|-1.78|
|[[:results:exp67|BVD-523 15μM R02 exp67]]|-1.76|
|[[:results:exp481|Ethambutol 25μM R08 exp481]]|-1.74|
|[[:results:exp357|Dorsomorphin 5μM R07 exp357]]|-1.71|
|[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|-1.7|
|[[:results:exp301|VER-155008 3.9μM R06 exp301]]|2.21|
^Gene^Correlation^
|[[:human genes:a:atp6v0a2|ATP6V0A2]]|0.639|
|[[:human genes:z:zfat|ZFAT]]|0.548|
|[[:human genes:a:atp6v1g1|ATP6V1G1]]|0.49|
|[[:human genes:c:cog7|COG7]]|0.456|
|[[:human genes:a:arl1|ARL1]]|0.455|
|[[:human genes:g:gpr107|GPR107]]|0.455|
|[[:human genes:c:cog5|COG5]]|0.427|
|[[:human genes:r:rgp1|RGP1]]|0.426|
|[[:human genes:s:sptlc2|SPTLC2]]|0.421|
|[[:human genes:p:pi4kb|PI4KB]]|0.417|
|[[:human genes:u:unc50|UNC50]]|0.413|
|[[:human genes:s:slc39a9|SLC39A9]]|0.409|
|[[:human genes:r:ruvbl2|RUVBL2]]|0.408|
|[[:human genes:p:prim1|PRIM1]]|0.408|
Global Fraction of Cell Lines Where Essential: 549/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|23/28|
|blood|23/28|
|bone|20/26|
|breast|23/33|
|central nervous system|28/56|
|cervix|3/4|
|colorectal|12/17|
|esophagus|8/13|
|fibroblast|1/1|
|gastric|12/16|
|kidney|20/21|
|liver|17/20|
|lung|52/75|
|lymphocyte|14/16|
|ovary|17/26|
|pancreas|21/24|
|peripheral nervous system|10/16|
|plasma cell|12/15|
|prostate|0/1|
|skin|19/24|
|soft tissue|6/9|
|thyroid|1/2|
|upper aerodigestive|20/22|
|urinary tract|24/29|
|uterus|5/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 1203
* **Expression level (log2 read counts)**: 5.62
{{:chemogenomics:nalm6 dist.png?nolink |}}